SOURCE: DSM N.V.

February 26, 2009 10:41 ET

DSM announces confirmation of credit ratings

HEERLEN, NETHERLANDS--(Marketwire - February 26, 2009) - Royal DSM N.V. (PINKSHEETS: RDSMY), the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that credit rating agencies Standard & Poor's and Moody's have confirmed their credit ratings for the company.

DSM aims to maintain a single A long-term credit rating for senior unsecured debt. Standard & Poor's has confirmed its 'A-' long-term and 'A-2' short term credit rating for DSM with a stable outlook. Moody's has confirmed its 'A3' long term and 'P-2' short term rating for the company, also with a stable outlook.

"We are very pleased with the confirmation of our credit rating by both agencies. This underlines our solid financial position. This will ensure that we will be able to pursue our strategy even during this period of economic downturn, when creditworthiness is more important than ever", Rolf-Dieter Schwalb, member of the DSM Managing Board and Chief Financial Officer said.

In DSM's financial policy, the company aims for a net debt which is between 30 and 40% of equity plus net debt in normal times (currently the objective is to stay below 30%) and an operating profit before amortization and depreciation (EBITDA) which is at least 8.5 times the balance of financial income and expense.

DSM - the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.

Contact Information

  • For more information:

    DSM Corporate Communications
    Elvira Luykx
    tel. +31 (0) 45 5782035
    fax +31 (0) 45 5740680
    e-mail
    Email Contact

    DSM Investor Relations
    Hans Vossen
    tel. +31 (0) 45 5782864
    fax +31 (0) 45 5782595
    e-mail
    Email Contact